Development of a nonhuman primate model for studying the consequences of long-term neuroprotectant administration on complex brain functions in developing animals.
Paule
M G
MG
Division of Neurotoxicology, National Center for Toxicological Research/FDA, Jefferson, Arkansas 72079-9502, USA. mpaule@nctr.fda.gov
Popke
E J
EJ
Pearson
E
E
Hammond
T
T
D000818:Animals; D001921:Brain / Q000187:drug effects* / Q000254:growth & development; D016291:Dizocilpine Maleate / Q000494:pharmacology; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D006801:Humans; D007858:Learning / Q000187:drug effects*; D017774:Long-Term Potentiation / Q000187:drug effects* / Q000502:physiology; D008253:Macaca mulatta; D018696:Neuroprotective Agents / Q000494:pharmacology*; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects
D018691:Excitatory Amino Acid Antagonists; D018696:Neuroprotective Agents; D016194:Receptors, N-Methyl-D-Aspartate; D016291:Dizocilpine Maleate